Pediatric Salivary Gland Malignancies

Robert A Ord1, Eric R Carlson2

  • 1Department of Oral and Maxillofacial Surgery, Baltimore College of Dental Surgery, University of Maryland and the Greenbaum Cancer Institute, Suite 1402, 650, West Baltimore Street, Baltimore, MD 21201, USA.

Insights

Pediatric malignant salivary gland tumors are rare but have better survival rates than adult cases. Surgical excision with negative margins is the primary treatment for these rare childhood cancers.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Tumor Biology

Background:

  • Malignant salivary gland tumors are exceptionally rare in children.
  • Despite rarity, the proportion of malignant tumors is higher in pediatric patients compared to adults.
  • Pediatric patients exhibit improved survival outcomes relative to adult counterparts.

Purpose of the Study:

  • To provide a comprehensive review of pediatric malignant salivary gland tumors.
  • To discuss current understandings of demographics, etiology, and management strategies.
  • To analyze treatment outcomes and survival data for this rare pediatric condition.

Main Methods:

  • Review of current literature on pediatric malignant salivary gland tumors.
  • Synthesis of information regarding epidemiology, causative factors, and treatment approaches.
  • Analysis of patient outcomes, including survival rates and prognostic indicators.

Main Results:

  • Pediatric malignant salivary gland tumors are infrequent but present with a higher malignancy rate than in adults.
  • Surgical excision aiming for negative margins is the cornerstone of treatment.
  • Pediatric patients generally experience better survival outcomes compared to adults.

Conclusions:

  • Malignant salivary gland tumors in children, though rare, require specialized management.
  • Effective treatment relies on complete surgical resection.
  • Ongoing research is crucial for improving the understanding and outcomes of these rare pediatric malignancies.

Related Concept Videos

Salivary Glands and Saliva01:23

Salivary Glands and Saliva

The salivary glands, of which there are three pairs known as the parotid, submandibular, and sublingual glands, play a crucial role in maintaining oral health and initiating the digestive process. Positioned near the ears, beneath the masseter muscle, the parotid glands secrete saliva into the oral cavity through the parotid duct of Stensen. Meanwhile, the submandibular glands, located on the floor of the mouth, secrete saliva through channels named submandibular ducts. The sublingual glands,...
3.2K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

2.8K
Exocrine Glands: Types of Secretions01:13

Exocrine Glands: Types of Secretions

Exocrine glands produce and release a variety of glandular products. Exocrine glands can be classified into serous, mucous, or mixed types based on their secretory products.
Serous glands produce watery secretions rich in digestive enzymes and proteins. The constituent cells of the serous gland have centrally located nuclei and eosinophilic secretory granules in the cytoplasm. The parotid gland is an example of a serous gland. It secretes saliva, which contains enzymes, such as lipases and...
4.5K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
330